WPRIM Management System> DCMS> Protein & Cell> 2021> 12> 5

Volume: 12 Issue: 5

1. A practical guide to amplicon and metagenomic analysis of microbiome data. Page:315—330
2. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy. Page:331—345
3. Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma. Page:374—393
4. Role of gut microbiota in identification of novel TCM-derived active metabolites. Page:394—410
5. Gut microbes in cardiovascular diseases and their potential therapeutic applications. Page:346—359
6. Targeting the alternative bile acid synthetic pathway for metabolic diseases. Page:411—425
7. Unexpected guests in the tumor microenvironment: microbiome in cancer. Page:426—435
8. The role of the gut microbiome and its metabolites in metabolic diseases. Page:360—373

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.